Tower Research Capital (TRC)’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,822
Closed -$3.73K 6194
2024
Q3
$3.73K Buy
2,822
+2,201
+354% +$2.91K ﹤0.01% 4783
2024
Q2
$4.72K Sell
621
-43
-6% -$327 ﹤0.01% 4746
2024
Q1
$5.98K Buy
664
+416
+168% +$3.74K ﹤0.01% 4457
2023
Q4
$2.66K Sell
248
-718
-74% -$7.7K ﹤0.01% 5183
2023
Q3
$5.8K Sell
966
-494
-34% -$2.97K ﹤0.01% 4686
2023
Q2
$10.1K Buy
1,460
+748
+105% +$5.16K ﹤0.01% 4148
2023
Q1
$11K Buy
+712
New +$11K ﹤0.01% 4301
2022
Q2
Sell
-1,047
Closed -$29K 6731
2022
Q1
$29K Buy
1,047
+329
+46% +$9.11K ﹤0.01% 3207
2021
Q4
$33K Buy
718
+482
+204% +$22.2K ﹤0.01% 3156
2021
Q3
$19K Sell
236
-170
-42% -$13.7K ﹤0.01% 3786
2021
Q2
$39K Buy
406
+79
+24% +$7.59K ﹤0.01% 3247
2021
Q1
$54K Sell
327
-1,580
-83% -$261K ﹤0.01% 3063
2020
Q4
$187K Buy
1,907
+1,835
+2,549% +$180K 0.01% 1763
2020
Q3
$2K Buy
+72
New +$2K ﹤0.01% 4638
2020
Q2
Sell
-2
Closed 5064
2020
Q1
$0 Sell
2
-20
-91% ﹤0.01% 4129
2019
Q4
$2K Sell
22
-178
-89% -$16.2K ﹤0.01% 3143
2019
Q3
$20K Buy
200
+142
+245% +$14.2K ﹤0.01% 2486
2019
Q2
$8K Buy
58
+39
+205% +$5.38K ﹤0.01% 2722
2019
Q1
$3K Sell
19
-11
-37% -$1.74K ﹤0.01% 3337
2018
Q4
$3K Buy
+30
New +$3K ﹤0.01% 3248
2018
Q3
Sell
-27
Closed -$58K 4366
2018
Q2
$58K Sell
27
-2
-7% -$4.3K ﹤0.01% 1766
2018
Q1
$71K Buy
29
+23
+383% +$56.3K 0.01% 1476
2017
Q4
$11K Buy
+6
New +$11K ﹤0.01% 2520
2017
Q3
Sell
-5
Closed -$4K 4344
2017
Q2
$4K Sell
5
-1
-17% -$800 ﹤0.01% 2140
2017
Q1
$4K Buy
+6
New +$4K ﹤0.01% 2372
2016
Q1
Sell
-1
Closed -$1K 5146
2015
Q4
$1K Buy
+1
New +$1K ﹤0.01% 4204
2014
Q4
Sell
-1
Closed -$1K 4859
2014
Q3
$1K Buy
+1
New +$1K ﹤0.01% 4188
2014
Q2
Sell
-13
Closed -$29K 3791
2014
Q1
$29K Buy
13
+5
+63% +$11.2K ﹤0.01% 1541
2013
Q4
$19K Buy
8
+1
+14% +$2.38K ﹤0.01% 2406
2013
Q3
$20K Buy
+7
New +$20K ﹤0.01% 2692